Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The effect of flavonoid derivatives on doxorubicin transport and metabolism

R Vaclavikova, E Kondrova, M Ehrlichova, A Boumendjel, J Kovar, P Stopka, P Soucek, I Gut

. 2008 ; 16 (4) : 2034-2042.

Language English Country Great Britain

Grant support
NR9426 MZ0 CEP Register

This study investigated the effect of naturally occurring flavonoids and synthetic aurone derivatives on the formation of cardiotoxic doxorubicinol and transport of doxorubicin in breast cancer cells. Quercetin significantly inhibited the formation of doxorubicinol. Quercetin and aurones did not significantly affect transport of [14C]doxorubicin in human resistant breast cancer cells. In conclusion, quercetin should be further tested for its potency to decrease doxorubicin-mediated toxicity.

References provided by Crossref.org

000      
02333naa 2200457 a 4500
001      
bmc10034925
003      
CZ-PrNML
005      
20140326133628.0
008      
101221s2008 xxk e eng||
009      
AR
024    __
$a 10.1016/j.bmc.2007.10.093 $2 doi
035    __
$a (PubMed)18024139
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Václavíková, Radka $7 xx0142918
245    14
$a The effect of flavonoid derivatives on doxorubicin transport and metabolism / $c R Vaclavikova, E Kondrova, M Ehrlichova, A Boumendjel, J Kovar, P Stopka, P Soucek, I Gut
314    __
$a Group for Biotransformations, Center of Occupational Medicine, National Institute of Public Health, Srobarova 48, 100 42 Prague 10, Czech Republic
520    9_
$a This study investigated the effect of naturally occurring flavonoids and synthetic aurone derivatives on the formation of cardiotoxic doxorubicinol and transport of doxorubicin in breast cancer cells. Quercetin significantly inhibited the formation of doxorubicinol. Quercetin and aurones did not significantly affect transport of [14C]doxorubicin in human resistant breast cancer cells. In conclusion, quercetin should be further tested for its potency to decrease doxorubicin-mediated toxicity.
650    _2
$a protinádorová antibiotika $7 D000903
650    _2
$a benzofurany $x farmakologie $7 D001572
650    _2
$a biologický transport $x účinky léků $7 D001692
650    _2
$a nádory prsu $7 D001943
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a doxorubicin $x analogy a deriváty $x farmakokinetika $x metabolismus $7 D004317
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a flavonoidy $x farmakologie $7 D005419
650    _2
$a lidé $7 D006801
650    _2
$a metabolismus $x účinky léků $7 D008660
650    _2
$a quercetin $x farmakologie $7 D011794
650    _2
$a financování organizované $7 D005381
700    1_
$a Kondrová, Eliška. $7 _AN043300
700    1_
$a Ehrlichová, Marie $7 xx0067467
700    1_
$a Boumendjel, A
700    1_
$a Kovář, Jan, $d 1952- $7 jn20040114001
700    1_
$a Stopka, Pavel, $d 1938- $7 xx0053305
700    1_
$a Souček, Pavel $7 xx0060511
700    1_
$a Gut, Ivan, $d 1936- $7 xx0060370
773    0_
$w MED00000769 $t Bioorganic & medicinal chemistry $g Roč. 16, č. 4 (2008), s. 2034-2042 $x 0968-0896
910    __
$a ABA008 $b x $y 7 $z 0
990    __
$a 20110223130147 $b ABA008
991    __
$a 20140326133703 $b ABA008
999    __
$a ok $b bmc $g 823362 $s 688788
BAS    __
$a 3
BMC    __
$a 2008 $b 16 $c 4 $d 2034-2042 $m Bioorganic & medicinal chemistry $n Bioorg Med Chem $x MED00000769
GRA    __
$a NR9426 $p MZ0
LZP    __
$a 2011-2B/ewme

Find record

Citation metrics

Loading data ...